vs
Healthpeak Properties（DOC）与EDGEWELL PERSONAL CARE Co（EPC）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是EDGEWELL PERSONAL CARE Co的1.7倍（$719.4M vs $422.8M），Healthpeak Properties净利率更高（73.2% vs -15.5%，领先88.7%），Healthpeak Properties同比增速更快（3.1% vs -11.6%），Healthpeak Properties自由现金流更多（$357.0M vs $-137.5M），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs -16.0%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
Edgewell个人护理是一家总部位于美国康涅狄格州谢尔顿的跨国消费品企业，主营业务聚焦个人护理产品领域。公司在2015年从劲量控股分拆后正式成立，目前在全球多个市场开展个人护理相关业务。
DOC vs EPC — 直观对比
营收规模更大
DOC
是对方的1.7倍
$422.8M
营收增速更快
DOC
高出14.7%
-11.6%
净利率更高
DOC
高出88.7%
-15.5%
自由现金流更多
DOC
多$494.5M
$-137.5M
两年增速更快
DOC
近两年复合增速
-16.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $719.4M | $422.8M |
| 净利润 | $114.0M | $-65.7M |
| 毛利率 | — | 38.1% |
| 营业利润率 | 17.4% | -4.5% |
| 净利率 | 73.2% | -15.5% |
| 营收同比 | 3.1% | -11.6% |
| 净利润同比 | 2406.4% | -3028.6% |
| 每股收益（稀释后） | $0.16 | $-1.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCEPC
| Q4 25 | $719.4M | $422.8M | ||
| Q3 25 | $705.9M | $600.5M | ||
| Q2 25 | $694.3M | $627.2M | ||
| Q1 25 | $702.9M | $580.7M | ||
| Q4 24 | $698.0M | $415.1M | ||
| Q3 24 | $700.4M | $517.6M | ||
| Q2 24 | $695.5M | $647.8M | ||
| Q1 24 | $606.6M | $599.4M |
净利润DOCEPC
| Q4 25 | $114.0M | $-65.7M | ||
| Q3 25 | $-117.1M | $-30.6M | ||
| Q2 25 | $31.7M | $29.1M | ||
| Q1 25 | $42.8M | $29.0M | ||
| Q4 24 | $4.5M | $-2.1M | ||
| Q3 24 | $85.9M | $8.8M | ||
| Q2 24 | $146.0M | $49.0M | ||
| Q1 24 | $6.7M | $36.0M |
毛利率DOCEPC
| Q4 25 | — | 38.1% | ||
| Q3 25 | 58.6% | 37.9% | ||
| Q2 25 | 60.2% | 42.8% | ||
| Q1 25 | 61.1% | 44.1% | ||
| Q4 24 | 60.3% | 41.6% | ||
| Q3 24 | 60.0% | 41.1% | ||
| Q2 24 | 60.6% | 44.3% | ||
| Q1 24 | 59.8% | 43.1% |
营业利润率DOCEPC
| Q4 25 | 17.4% | -4.5% | ||
| Q3 25 | 9.2% | -4.2% | ||
| Q2 25 | 5.7% | 8.6% | ||
| Q1 25 | 7.7% | 10.1% | ||
| Q4 24 | -2.2% | 2.2% | ||
| Q3 24 | 14.1% | 3.9% | ||
| Q2 24 | 22.3% | 12.8% | ||
| Q1 24 | 3.7% | 11.7% |
净利率DOCEPC
| Q4 25 | 73.2% | -15.5% | ||
| Q3 25 | -16.6% | -5.1% | ||
| Q2 25 | 4.6% | 4.6% | ||
| Q1 25 | 6.1% | 5.0% | ||
| Q4 24 | 0.7% | -0.5% | ||
| Q3 24 | 12.3% | 1.7% | ||
| Q2 24 | 21.0% | 7.6% | ||
| Q1 24 | 1.1% | 6.0% |
每股收益（稀释后）DOCEPC
| Q4 25 | $0.16 | $-1.41 | ||
| Q3 25 | $-0.17 | $-0.65 | ||
| Q2 25 | $0.05 | $0.62 | ||
| Q1 25 | $0.06 | $0.60 | ||
| Q4 24 | $0.02 | $-0.04 | ||
| Q3 24 | $0.12 | $0.18 | ||
| Q2 24 | $0.21 | $0.98 | ||
| Q1 24 | $0.01 | $0.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | — |
| 总债务越低越好 | $9.8B | $1.5B |
| 股东权益账面价值 | $7.5B | $1.5B |
| 总资产 | $20.3B | $3.8B |
| 负债/权益比越低杠杆越低 | 1.31× | 1.03× |
8季度趋势，按日历期对齐
现金及短期投资DOCEPC
| Q4 25 | $467.5M | — | ||
| Q3 25 | $91.0M | — | ||
| Q2 25 | $89.4M | — | ||
| Q1 25 | $70.6M | — | ||
| Q4 24 | $119.8M | — | ||
| Q3 24 | $180.4M | $209.1M | ||
| Q2 24 | $106.9M | — | ||
| Q1 24 | $101.8M | — |
总债务DOCEPC
| Q4 25 | $9.8B | $1.5B | ||
| Q3 25 | $9.1B | $1.4B | ||
| Q2 25 | $9.0B | $1.4B | ||
| Q1 25 | $8.9B | $1.4B | ||
| Q4 24 | $8.7B | $1.4B | ||
| Q3 24 | $8.6B | $1.3B | ||
| Q2 24 | $8.6B | $1.3B | ||
| Q1 24 | $8.8B | $1.4B |
股东权益DOCEPC
| Q4 25 | $7.5B | $1.5B | ||
| Q3 25 | $7.6B | $1.6B | ||
| Q2 25 | $7.9B | $1.6B | ||
| Q1 25 | $8.2B | $1.5B | ||
| Q4 24 | $8.4B | $1.5B | ||
| Q3 24 | $8.6B | $1.6B | ||
| Q2 24 | $8.8B | $1.6B | ||
| Q1 24 | $8.9B | $1.6B |
总资产DOCEPC
| Q4 25 | $20.3B | $3.8B | ||
| Q3 25 | $19.6B | $3.8B | ||
| Q2 25 | $19.8B | $3.8B | ||
| Q1 25 | $19.8B | $3.8B | ||
| Q4 24 | $19.9B | $3.7B | ||
| Q3 24 | $20.0B | $3.7B | ||
| Q2 24 | $20.2B | $3.7B | ||
| Q1 24 | $20.5B | $3.8B |
负债/权益比DOCEPC
| Q4 25 | 1.31× | 1.03× | ||
| Q3 25 | 1.20× | 0.89× | ||
| Q2 25 | 1.14× | 0.88× | ||
| Q1 25 | 1.08× | 0.95× | ||
| Q4 24 | 1.04× | 0.97× | ||
| Q3 24 | 1.00× | 0.81× | ||
| Q2 24 | 0.98× | 0.82× | ||
| Q1 24 | 0.99× | 0.88× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $-125.9M |
| 自由现金流经营现金流 - 资本支出 | $357.0M | $-137.5M |
| 自由现金流率自由现金流/营收 | 49.6% | -32.5% |
| 资本支出强度资本支出/营收 | 124.4% | 2.7% |
| 现金转化率经营现金流/净利润 | 10.99× | — |
| 过去12个月自由现金流最近4个季度 | — | $36.3M |
8季度趋势，按日历期对齐
经营现金流DOCEPC
| Q4 25 | $1.3B | $-125.9M | ||
| Q3 25 | $315.0M | $74.1M | ||
| Q2 25 | $363.5M | $114.8M | ||
| Q1 25 | $279.4M | $45.1M | ||
| Q4 24 | $1.1B | $-115.6M | ||
| Q3 24 | $318.2M | $-388.3M | ||
| Q2 24 | $316.2M | $101.2M | ||
| Q1 24 | $152.6M | $129.0M |
自由现金流DOCEPC
| Q4 25 | $357.0M | $-137.5M | ||
| Q3 25 | — | $46.5M | ||
| Q2 25 | — | $99.3M | ||
| Q1 25 | — | $28.0M | ||
| Q4 24 | $333.7M | $-132.4M | ||
| Q3 24 | — | $-414.2M | ||
| Q2 24 | — | $88.6M | ||
| Q1 24 | — | $117.5M |
自由现金流率DOCEPC
| Q4 25 | 49.6% | -32.5% | ||
| Q3 25 | — | 7.7% | ||
| Q2 25 | — | 15.8% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | 47.8% | -31.9% | ||
| Q3 24 | — | -80.0% | ||
| Q2 24 | — | 13.7% | ||
| Q1 24 | — | 19.6% |
资本支出强度DOCEPC
| Q4 25 | 124.4% | 2.7% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | — | 2.5% | ||
| Q1 25 | — | 2.9% | ||
| Q4 24 | 105.6% | 4.0% | ||
| Q3 24 | — | 5.0% | ||
| Q2 24 | — | 1.9% | ||
| Q1 24 | — | 1.9% |
现金转化率DOCEPC
| Q4 25 | 10.99× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 11.48× | 3.95× | ||
| Q1 25 | 6.52× | 1.56× | ||
| Q4 24 | 235.43× | — | ||
| Q3 24 | 3.71× | -44.13× | ||
| Q2 24 | 2.17× | 2.07× | ||
| Q1 24 | 22.85× | 3.58× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
暂无分部数据
EPC
| Other | $242.0M | 57% |
| Sunand Skin Care Segment | $131.5M | 31% |
| Shavinggelsandcreams | $32.3M | 8% |
| Wipes And Other Skin Care Products | $17.0M | 4% |
